About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Dr. Ana Cuenda, researcher at the National Center of Biotechnology, Madrid
Abstract: p38MAPK pathways are central to inflammatory processes. The p38MAPK group has four members encoded by different genes, p38α, p38β, p38γ and p38δ. While the roles of the p38α isoform have been widely studied in the context of inflammation and tumour development, the knowledge of the in vivo role of p38γ and p38δ in these processes is still very limited. Our laboratory studies essential functions of these two less studied alternative p38MAPKs, in vivo and in cultured cells. This strategy has led to the discovery of unexpected cross talk between p38γ/p38δ and ERK1/2 pathway controlling cytokine production in cells during inflammation. The regulation of inflammatory processes by p38γ/p38δ has an impact in the development of different diseases such as colon and skin inflammation, arthritis, or colon cancer associated to colitis. We will discuss how, in specific settings, the p38MAPK components, p38γ and p38δ, operate in inflammatory processes, and the mechanisms underlying these unexpected functions.
Host: Dr. José Miguel Lizcano De Vega, Protein kinases in cancer research (VHIR)
Register here to attend by Zoom https://gencat.zoom.us/j/92726233337